Vivacta Limited is a medical diagnostic company that is developing a
patented ultra-sensitive Piezofilm-based technique for rapid
point-of-care (PoC) testing. This novel technology can quickly
deliver a laboratory quality analysis of whole blood samples,
without the need for cell separation.
Based in the Kent Science Park and employing over 20 scientists,
Vivacta has strong venture capital funding and an ambitious growth
strategy designed to rapidly commercialise its innovative product.
Vivacta will initially offer a TSH test, but aims to partner larger
diagnostic companies to provide immunoassay and molecular diagnostic
tests to all parts of the fast-growing point-of-care (PoC) market.
100 Guillat Avenue